Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic Surgery [NA]

View source ↗

Summary

A clinical trial is evaluating dexamethasone palmitate to prevent postoperative nausea and vomiting after minimally invasive endoscopic surgery; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone Palmitate (dexamethasone palmitate)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postoperative Nausea and Vomiting, Dexamethasone Palmitate | NA | Status: RECRUITING